L-Lactic acid

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Phexxi, Prismasol
Generic Name
L-Lactic acid
DrugBank Accession Number
DB14475
Background

Not Available

Type
Small Molecule
Groups
Approved, Experimental
Structure
Weight
Average: 90.0779
Monoisotopic: 90.031694058
Chemical Formula
C3H6O3
Synonyms
  • (+)-lactic acid
  • (S)-(+)-lactic acid
  • (S)-2-hydroxypropanoic acid
  • (S)-2-hydroxypropionic acid
  • (S)-lactic acid
  • L-(+)-lactic acid
  • L-(+)-α-hydroxypropionic acid
  • L-Lactic acid
  • L-Milchsäure

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
PhexxiL-Lactic acid (90 mg/5g) + Citric acid monohydrate (50 mg/5g) + Potassium bitartrate (20 mg/5g)GelVaginalEvofem, Inc.2020-08-01Not applicableUS flag
Prismasol 2L-Lactic acid (5.400 g / 1000 mL) + Calcium chloride (5.145 g / 1000 mL) + D-glucose (22.00 g / 1000 mL) + Magnesium chloride (2.033 g / 1000 mL) + Potassium chloride (0.157 g / 1000 mL) + Sodium bicarbonate (3.090 g / 1000 mL) + Sodium chloride (6.450 g / 1000 mL)SolutionHemodialysis; IntravenousBaxter Laboratories2006-02-21Not applicableCanada flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Hydroxy acids and derivatives
Sub Class
Alpha hydroxy acids and derivatives
Direct Parent
Alpha hydroxy acids and derivatives
Alternative Parents
Secondary alcohols / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
Substituents
Alcohol / Aliphatic acyclic compound / Alpha-hydroxy acid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic oxide / Organic oxygen compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
2-hydroxypropanoic acid (CHEBI:422)
Affected organisms
Not Available

Chemical Identifiers

UNII
F9S9FFU82N
CAS number
79-33-4
InChI Key
JVTAAEKCZFNVCJ-REOHCLBHSA-N
InChI
InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1
IUPAC Name
(2S)-2-hydroxypropanoic acid
SMILES
C[C@H](O)C(O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0000190
KEGG Compound
C00186
ChemSpider
96860
RxNav
2462499
ChEBI
422
ChEMBL
CHEMBL330546
ZINC
ZINC000004658560
PDBe Ligand
2OP
PDB Entries
1tj0 / 1tj1 / 1vq4 / 1vq5 / 1vq7 / 1w9n / 2vk8 / 2voj / 2w11 / 2wnz
show 27 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0RecruitingBasic ScienceBacterial Vaginosis (BV) / Vulvovaginal Candidiasis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelVaginal
SolutionHemodialysis; Intravenous
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)Region
US10568855No2020-02-252033-03-15US flag
US6706276No2004-03-162022-03-06US flag
US11337989No2013-03-152033-03-15US flag
US11439610No2013-03-152033-03-15US flag

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility562.0 mg/mLALOGPS
logP-0.79ALOGPS
logP-0.47Chemaxon
logS0.79ALOGPS
pKa (Strongest Acidic)3.78Chemaxon
pKa (Strongest Basic)-3.7Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area57.53 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity18.84 m3·mol-1Chemaxon
Polarizability8.06 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-00kb-0900000000-fb59ec16914501aa19ab
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0006-9000000000-a3691f383d440fb00e1f
GC-MS Spectrum - EI-BGC-MSsplash10-014j-0900000000-c4d9e12b4b0150eda54b
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00kb-0900000000-fb59ec16914501aa19ab
Mass Spectrum (Electron Ionization)MSsplash10-002b-9000000000-50213d6b39ef9741c466
MS/MS Spectrum - Quattro_QQQ 10V, NegativeLC-MS/MSsplash10-000i-9000000000-1d5a5f55463acefb6fc7
MS/MS Spectrum - Quattro_QQQ 25V, NegativeLC-MS/MSsplash10-000m-9000000000-c07133799d8f43d4c75a
MS/MS Spectrum - Quattro_QQQ 40V, NegativeLC-MS/MSsplash10-000i-9000000000-ddb080250741e69ab137
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, NegativeLC-MS/MSsplash10-000i-9000000000-8f5d5eddb0b4b2a3b541
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, NegativeLC-MS/MSsplash10-000i-9000000000-3bcfc4cdc49230f15642
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, NegativeLC-MS/MSsplash10-0006-9000000000-48b511409f4f60cec04e
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, NegativeLC-MS/MSsplash10-0006-9000000000-365ea3c1bcfff2cab938
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, NegativeLC-MS/MSsplash10-0006-9000000000-9d0238aeeb837213e81d
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-9000000000-8f5d5eddb0b4b2a3b541
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-9000000000-3bcfc4cdc49230f15642
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9000000000-48b511409f4f60cec04e
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9000000000-365ea3c1bcfff2cab938
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9000000000-9d0238aeeb837213e81d
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-9000000000-b5a4f0cdc18a45622b3b
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-9000000000-ebec237b829c4f47b934
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-00dr-9000000000-633a0904f91963b61b22
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-9000000000-a3a400c5ff0a137c6549
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0007-9000000000-51f2d94939ebbac87aa5
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-9000000000-164578dc216a66b093b0
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,1H] 2D NMR Spectrum2D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-108.4461215
predicted
DarkChem Lite v0.1.0
[M-H]-108.5550215
predicted
DarkChem Lite v0.1.0
[M-H]-108.5330215
predicted
DarkChem Lite v0.1.0
[M-H]-117.44805
predicted
DeepCCS 1.0 (2019)
[M+H]+109.2184215
predicted
DarkChem Lite v0.1.0
[M+H]+110.9467215
predicted
DarkChem Lite v0.1.0
[M+H]+109.0196215
predicted
DarkChem Lite v0.1.0
[M+H]+120.247345
predicted
DeepCCS 1.0 (2019)
[M+Na]+108.8337215
predicted
DarkChem Lite v0.1.0
[M+Na]+108.9939215
predicted
DarkChem Lite v0.1.0
[M+Na]+108.8913215
predicted
DarkChem Lite v0.1.0
[M+Na]+128.415
predicted
DeepCCS 1.0 (2019)

Drug created at July 06, 2018 16:17 / Updated at February 21, 2021 18:54